Terminated PHASE3 INTERVENTIONAL 2-arm NCT00048750

Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU

A Phase 3, Randomized,Double-Blind, Comparative Study of Micafungin (FK463) Versus Placebo as Preemptive Prophylactic Antifungal Therapy in Patients in the Intensive Care Unit

Sponsor: Astellas Pharma Inc

Conditions Invasive Fungal Infections

Interventions Micafungin Placebo

Updated 7 times since 2017 Last updated: Mar 26, 2012 Started: Jan 31, 2003 Primary completion: Jun 30, 2003 Completion: Jun 30, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Inadequate enrollment

Other terminated trials from Astellas Pharma Inc

More terminations from Astellas Pharma Inc

Other Invasive Fungal Infections trials with similar outcome

NCT05534529 · Phase PHASE1 · Oct 2024

Browse all Invasive Fungal Infections trials

This PHASE3 trial investigates Invasive Fungal Infections and is currently terminated or withdrawn. Astellas Pharma Inc leads this study, which shows 7 recorded versions since 2003 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE3
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Terminated PHASE3
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE3

First recorded

Jan 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Astellas Pharma Inc

Data source: Astellas Pharma Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlanta, United States , Baltimore, United States , Birmingham, United States , Boston, United States , Charlottesville, United States , Cincinnati, United States , Dallas, United States , Denver, United States , Detroit, United States , Durham, United States and 32 more locations